June 25, 2014 -The genetics startup 23andMe said on Friday it is one step closer to resuming sales of its full-fledged health product, with the U.S. Food and Drug Administration accepting its first health report for review. The home genetics …

Genetics Startup 23andMe takes Step on Path to FDA Approval Read more »